BamSEC and AlphaSense Join Forces
Learn More

Millennium Pharmaceuticals Inc

Indentures Filter

EX-4.1
from 8-K 7 pages Amendment to the Rights Agreement
12/34/56
EX-4.1
from 8-K 87 pages Millennium Pharmaceuticals, Inc. as Issuer and U.S. Bank National Association as Trustee Indenture Dated as of November 15, 2006 $250,000,000 2.25% Convertible Senior Notes Due November 15, 2011 Recitals
12/34/56
EX-4.5
from S-3ASR 63 pages Millennium Pharmaceuticals, Inc. as Issuer and U.S. Bank National Association as Trustee Indenture Dated as of November [ ], 2006 $[ ],000,000 [ ]% Convertible Senior Notes Due November 15, 2011 Recitals
12/34/56
EX-4.2
from 8-K ~5 pages 3rd Supplemental Indenture to the 5 % Notes
12/34/56
EX-4.1
from 8-K ~5 pages 3rd Supplemental Indenture to the 4.5% Notes
12/34/56
EX-4.3
from S-3 ~5 pages Second Supplemental Indenture
12/34/56
EX-4.6
from 8-K ~5 pages Indenture or similar
12/34/56
EX-4.2
from S-3 ~5 pages First Supplemental Indenture
12/34/56
EX-4.5
from 8-K ~20 pages Indenture or similar
12/34/56
EX-4
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.1
from 8-K ~50 pages Rights Agreement
12/34/56
EX-4.2
from S-3 ~50 pages Indenture or similar
12/34/56
EX-4.1
from S-3 ~50 pages Indenture or similar
12/34/56
EX-4.4
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.1
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.3
from S-3 ~10 pages Indenture or similar
12/34/56
EX-4.2
from 10-K405 >50 pages Indenture or similar
12/34/56
EX-4.2
from 10-Q ~10 pages Restated By-Laws of the Registrant
12/34/56
EX-4.1
from 10-Q ~10 pages Restated Certificate of Incorporation
12/34/56